Back to Journals » Therapeutics and Clinical Risk Management » Volume 14

Increased risk of adverse drug events secondary to bevacizumab treatment in patients with advanced or metastatic breast cancer: a meta-analysis of randomized controlled trials

Total article views   Abstract views HTML views PDF downloads Totals
5,465 Dovepress* 4,804 359+ 772 5,163
PubMed Central* 0 302 110 302
Totals 4,804 661 882 5,465
*Since 4 May 2018
+Since July 2016

View citations on PubMed Central and Google Scholar